Decitabine in Treating Patients With Advanced Refractory Solid Tumors or Lymphomas

Clinical trial NCT00089089 · TERMINATED

Trial details

NCT number: NCT00089089
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Hematopoietic/Lymphoid Cancer Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2004-09-01
Primary completion: 2008-03-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.